Road to Commercialization

Sona’s next steps: Road to THT Commercialization

Potential future clinical studies to provide multiple valuation catalysts

Study of biopharma company acquisition valuation lifts by lead product development phase


Mean acquisition valuation increase: 

Study data cited is not for medical devices or therapies and may not relate directly to other companies or non-biopharma products or therapies. 

Bentley Biomedical as Regulatory Affairs Advisor

 Bentley Biomedical Consulting to advise on all regulatory, pre-clinical and clinical study preparations & oversight

Bentley Biomedical Consulting to advise on all regulatory, pre-clinical and clinical study preparations & oversight

“I am excited to begin working with Sona on the development of its targeted hyperthermia therapy (THT) and I look forward to working with THT • Lackofstructuralcomplexity developer Len Pagliaro to take it to the next level as the Company develops pre-clinical studies as it prepares to submit for an IDE and eventual clinical trials for this innovative therapy. THT offers the potential for a significant leap forward for colorectal cancer therapy and understanding the opportunities and demands of the regulatory environment will be key to the Company’s near and medium-term success.”
- Shepard Bentley

Other GNRs Applications

Sit egestas luctus ac dolor, porttitor. Massa quam consectetur feugiat maecenas in tellus, eget rhoncus. Elementum est odio.

Subscribe to Our Newsletter

Download the Company Presentation

Download the Latest White Paper

The Case for “Hyperthermia” Thermal Therapy for Cancer
2023-05-08

This is a staging enviroment